Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
about
HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating TregsEndothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans.The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.
P2860
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
@en
type
label
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
@en
prefLabel
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
@en
P2093
P1433
P1476
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
@en
P2093
Christophe Legendre
Dany Anglicheau
Marion Rabant
P304
P356
10.1016/J.HUMIMM.2016.05.021
P577
2016-05-26T00:00:00Z